SQZ Biotechnologies Company (SQZB) Financials

SQZB Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 29.8 million 27.9 million
June 30, 2023 54.1 million 29.6 million
March 31, 2023 73.2 million 33.0 million
Dec. 31, 2022 107.2 million 50.0 million

SQZB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -14.5 million 983000
June 30, 2023 -15.3 million 1.2 million
March 31, 2023 -23.8 million 695000
Dec. 31, 2022 -20.9 million 1.8 million

SQZB Net Income

No data available :(

SQZB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 10.2 million - 21.5 million
June 30, 2023 24.7 million - 22.4 million
March 31, 2023 39.9 million - 24.5 million
Dec. 31, 2022 63.7 million - 27.5 million

SQZB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 29.5 million
June 30, 2023 29.5 million
March 31, 2023 29.5 million
Dec. 31, 2022 29.5 million

SQZB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 10.5 million 5.6 million -
June 30, 2023 47000 10.5 million 4.6 million -
March 31, 2023 65000 13.0 million 2.2 million -3.1 million
Dec. 31, 2022 101000 14.9 million 2.8 million -2.7 million

SQZB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 2.2 million
June 30, 2023 178000 2.2 million
March 31, 2023 - 3.1 million
Dec. 31, 2022 11.9 million 3.4 million

SQZB

Price: $0.02

52 week price:
0.02
0.07

Earnings Per Share: -2.44 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 707787

Links: